1st 3 patients will be dosed one month apart per FDA guidelines.
if there are early signals, expansion into phase 2 can happen seemlessly for those indications due to the trial design.
Ann: First patient dosed in Phase 1/2 trial of CHM CDH17, page-7
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(4.17%) |
Mkt cap ! $11.21M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $2.657K | 235.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1428738 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 1161817 | 4 |
View Market Depth
| Last trade - 11.54am 06/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |